» Articles » PMID: 36434016

Successful Tracheal Regeneration Using Biofabricated Autologous Analogues Without Artificial Supports

Overview
Journal Sci Rep
Specialty Science
Date 2022 Nov 26
PMID 36434016
Authors
Affiliations
Soon will be listed here.
Abstract

Tracheas have a tubular structure consisting of cartilage rings continuously joined by a connective tissue membrane comprising a capillary network for tissue survival. Several tissue engineering efforts have been devoted to the design of scaffolds to produce complex structures. In this study, we successfully fabricated an artificial materials-free autologous tracheal analogue with engraftment ability by combining in vitro cell self-aggregation technique and in-body tissue architecture. The cartilage rings prepared by aggregating chondrocytes on designated culture grooves that induce cell self-aggregation were alternately connected to the connective tissues to form tubular tracheal analogues by subcutaneous embedding as in-body tissue architecture. The tracheal analogues allogeneically implanted into the rat trachea matured into native-like tracheal tissue by covering of luminal surfaces by the ciliated epithelium with mucus-producing goblet cells within eight months after implantation, while maintaining their structural integrity. Such autologous tracheal analogues would provide a foundation for further clinical research on the application of tissue-engineered tracheas to ensure their long-term functionality.

Citing Articles

Diverse Shape Design and Physical Property Evaluation of In-Body Tissue Architecture-Induced Tissues.

Tajikawa T, Sekido Y, Mori K, Kawashima T, Nakashima Y, Miyamoto S Bioengineering (Basel). 2024; 11(6).

PMID: 38927834 PMC: 11200934. DOI: 10.3390/bioengineering11060598.


Development of Subcutaneous SSEA3- or SSEA4-Positive Cell Capture Device.

Nakayama Y, Iwai R Bioengineering (Basel). 2024; 11(6).

PMID: 38927821 PMC: 11200914. DOI: 10.3390/bioengineering11060585.


Regeneration Process of an Autologous Tissue-Engineered Trachea (aTET) in a Rat Patch Tracheoplasty Model.

Iwasaki S, Deguchi K, Iwai R, Nakayama Y, Okuyama H Bioengineering (Basel). 2024; 11(3).

PMID: 38534518 PMC: 10968659. DOI: 10.3390/bioengineering11030243.


Pre-epithelialized cryopreserved tracheal allograft for neo-trachea flap engineering.

Zeng N, Chen Y, Wu Y, Zang M, Largo R, Chang E Front Bioeng Biotechnol. 2023; 11:1196521.

PMID: 37214293 PMC: 10198577. DOI: 10.3389/fbioe.2023.1196521.

References
1.
Higashita R, Miyazaki M, Oi M, Ishikawa N . First-in-human results of an in-body tissue architecture-induced tissue-engineered vascular graft "Biotube" for application in distal bypass for chronic limb-threatening ischemia. J Vasc Surg Cases Innov Tech. 2022; 8(3):488-493. PMC: 9424347. DOI: 10.1016/j.jvscit.2022.07.007. View

2.
Jiang X, Khan M, Tian W, Beilke J, Natarajan R, Kosek J . Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection. J Clin Invest. 2011; 121(6):2336-49. PMC: 3104770. DOI: 10.1172/JCI46192. View

3.
Yamada D, Nakamura M, Takao T, Takihira S, Yoshida A, Kawai S . Induction and expansion of human PRRX1 limb-bud-like mesenchymal cells from pluripotent stem cells. Nat Biomed Eng. 2021; 5(8):926-940. DOI: 10.1038/s41551-021-00778-x. View

4.
Kawashima T, Umeno T, Terazawa T, Wada T, Shuto T, Nishida H . Aortic valve neocuspidization with in-body tissue-engineered autologous membranes: preliminary results in a long-term goat model. Interact Cardiovasc Thorac Surg. 2021; 32(6):969-977. PMC: 8691585. DOI: 10.1093/icvts/ivab015. View

5.
Yap K, Yeoh G, Morrison W, Mitchell G . The Vascularised Chamber as an In Vivo Bioreactor. Trends Biotechnol. 2018; 36(10):1011-1024. DOI: 10.1016/j.tibtech.2018.05.009. View